FINWIRES · TerminalLIVE
FINWIRES

Vertiv's Long-Term Growth Story Continues With Q1 Earnings Beat, Guidance Raise, RBC Says

By

Vertiv's (VRT) long-term growth story continues as it posted a "high-quality" Q1 earnings beat and raised guidance, RBC Capital Markets said in a Wednesday note.

AI infrastructure demand from hyperscalers, colocation data centers, and new cloud players continue to fuel Vertiv's growth, as shown with US sales up 44% organically and a growing project pipeline, RBC analysts said.

Even amid tariffs and headwinds related to capacity growth, the company surprisingly lifted its full-year earnings before interest and taxes margin guidance, the analysts said. They said they appreciated Vertiv's pricing power, driven by strong demand and pre-built integrated data center white space and construction services.

The analysts believe that the company has the ample flexibility to invest in capacity expansions, new products such as 800V technology, and bolt-on acquisitions.

RBC increased its 2026 EPS estimates for Vertiv to $6.40 from $6.15, and 2027 EPS estimates to $8.60 from $8.30.

RBC reiterated the company's stock rating at outperform and raised the price target to $356 from $344.

Price: $321.99, Change: $+16.85, Percent Change: +5.52%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS